Jim Geraghty

Jim serves as chair of the board of directors of Idera Pharmaceuticals, Orchard Therapeutics, and Pieris Pharmaceuticals, and as a director of Fulcrum Therapeutics. He was previously an entrepreneur-in-residence at Third Rock Ventures and served earlier as senior vice president Strategy and Business Development at Sanofi. Jim held wide-ranging leadership positions at Genzyme, including senior vice president International Development, president of Genzyme Europe, general manager Cardiovascular, and chair and chief executive officer of Genzyme Transgenics. Jim started his career at Bain & Company. He has a B.A. from Georgetown, an M.S. from the University of Pennsylvania, and a J.D. from Yale.